4Shravat BP, Huseyin TS, Hynes KA. NICE guideline for the management of head injury: an audit demonstrating its impact on a district general hospital, with a cost analysis for England and Wales [J]. Emerg Med J, 2006; 23 (2) : 109 -113.
7Hodde NM, Engelberg RA, Treece PD, et al. Factors associated with nurse assessment of the quality of dying and death in the intensivecare unit [J]. Crit Care Med, 2004, 32 (8): 1648 - 1653.
5Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thrombembolic disease. Chest, 2001,119(suppl):176- 193.
6Macdonald RL, Amidei C, Lin G, et al. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing eraniotomy. Neurosurg, 1999, 45(2) :245 - 252.
7Ahman R, Scazziota A, Rouvier J. Efficacy of unfractionated heparln,low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor. Haemostasis. 1998, 28 (5):229235.
8Gerlach R, Scheuer T, Beck J, et al. Surgery after early nadroparin administration: results of aprospectives study. Neurosurgery, 2003, 53(5) : 1028 - 1034.
9AgnelliG, Pivella F, Buoneristiani P, et al. Enoxapafin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med, 1998,339(1) :80 - 85.
10Iorio A, Agnelli G. Low - molecular - weight and unfiactionated heparin for prevention of venous thromboemholism in neurosurgery:. Arch Intern Med.2000,160(15) :2327 - 2332.
